Verition Fund Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.07M | Buy |
218,586
+188,668
| +631% | +$3.52M | 0.02% | 997 |
|
|
2025
Q1 | $573K | Buy |
+29,918
| New | +$573K | ﹤0.01% | 1918 |
|
|
2024
Q4 | – | Sell |
-31,743
| Closed | -$1.35M | – | 2794 |
|
|
2024
Q3 | $1.35M | Sell |
31,743
-16,699
| -34% | -$708K | 0.01% | 1164 |
|
|
2024
Q2 | $1.95M | Buy |
48,442
+3,474
| +8% | +$140K | 0.01% | 886 |
|
|
2024
Q1 | $1.59M | Buy |
+44,968
| New | +$1.59M | 0.01% | 954 |
|
|
2023
Q4 | – | Sell |
-19,638
| Closed | -$408K | – | 2215 |
|
|
2023
Q3 | $408K | Buy |
19,638
+8,487
| +76% | +$176K | ﹤0.01% | 1274 |
|
|
2023
Q2 | $274K | Buy |
11,151
+2,010
| +22% | +$49.3K | ﹤0.01% | 1395 |
|
|
2023
Q1 | $371K | Buy |
+9,141
| New | +$371K | 0.01% | 1281 |
|
|
2022
Q2 | – | Sell |
-6,663
| Closed | -$775K | – | 2410 |
|
|
2022
Q1 | $775K | Sell |
6,663
-301
| -4% | -$35K | 0.01% | 1073 |
|
|
2021
Q4 | $1.05M | Buy |
6,964
+144
| +2% | +$21.7K | 0.01% | 879 |
|
|
2021
Q3 | $814K | Buy |
6,820
+2,853
| +72% | +$341K | 0.01% | 796 |
|
|
2021
Q2 | $386K | Buy |
3,967
+1,083
| +38% | +$105K | ﹤0.01% | 1091 |
|
|
2021
Q1 | $255K | Buy |
+2,884
| New | +$255K | ﹤0.01% | 1096 |
|
|
2020
Q1 | – | Sell |
-3,629
| Closed | -$216K | – | 937 |
|
|
2019
Q4 | $216K | Buy |
+3,629
| New | +$216K | ﹤0.01% | 828 |
|
|
2019
Q3 | – | Sell |
-8,765
| Closed | -$566K | – | 1202 |
|
|
2019
Q2 | $566K | Sell |
8,765
-18,535
| -68% | -$1.2M | 0.02% | 539 |
|
|
2019
Q1 | $1.73M | Buy |
+27,300
| New | +$1.73M | 0.07% | 217 |
|